To date, only six imported cases of human TBE from Scandinavia, Austria, Kyrgyzstan, and Slovenia were detected at the Belgian TBE National Reference Centre (NRC: WIV-ISP, Brussels, Belgium). However, seroconverted dogs, cattle, and roe deer have been found ([@CIT0001]--[@CIT0004]); therefore, the risk for emergence of tick-borne encephalitis virus (TBEV) in Belgium remains high.

TBEV-seropositivity has been observed in Eurasian wild boar (*Sus scrofa*) in several European countries. The seroprevalence in this species may exceed that of other hosts ([@CIT0005], [@CIT0006]) and at sufficient sample sizes wild boar studies allow spatial interpretations at the municipality level ([@CIT0006]).

Methods {#S0002}
=======

We used Flemish wild boar sera collected in 2013, within the frame of disease surveillance that was focused on Aujeszky\'s disease, Classical swine fever, and Brucellosis ([@CIT0007]). The total target population size was estimated at roughly 3,000 heads (M. Vervaeke -- ANB, pers. comm.). A total of 238 representative sera were obtained by veterinarians from the two Flemish wild boar subpopulations in different provinces: Limburg+Antwerp (LIM: *n*=161) and West Flanders (WFL: *n*=77). The study population and its seroprevalence ([Fig. 1](#F0001){ref-type="fig"}) were mapped using QGIS^®^2.2-Valmiera ([www.qgis.org/](http://www.qgis.org/)), using a vector layer of Flanders in the Belgian Lambert 1972 EPSG-projection. Sample size calculations for disease detection and probability of freedom were performed in Survey Toolbox^®^1.04 ([www.epitools.ausvet.com.au](http://www.epitools.ausvet.com.au)) and in WinEpiscope^®^2.0 ([www.wageningenur.nl/](http://www.wageningenur.nl/)).

![Map of Wild boar sampling (left) and TBEV-seropositives (right) in Flanders. Left Part: Study population and positives per community; Right Part: Calculated wild boar TBEV-seroprevalence based on 10 SNT-reactors (positive/borderline -- cut-off 1/10) out of 238 wild boar tested. FLA: Flanders total study population (*n*=238); WFL: West Flanders subpopulation (*n*=77); LIM: Limburg+Antwerp subpopulation (*n*=161).](IEE-6-31099-g001){#F0001}

A TBEV-specific retrospective serological screening was performed. Immunoglobulin of subtype G (IgG) antibodies were first detected by a commercial veterinary TBEV-ELISA (Immunozym FSME/TBE IgG All-Species-ELISA^®^, Progen Biotechnik GmbH, Germany). Then, neutralising TBEV-specific antibodies were titrated for all samples using a seroneutralisation test (SNT) and two cut-off titres (1/10--1/15) ([@CIT0003], [@CIT0008]). This test is considered to be the gold standard for medical and veterinary diagnosis of TBE ([@CIT0009], [@CIT0010]). Our final interpretation of the TBEV test results and the calculated prevalence were based on this test.

Cross-reactivity was excluded for those TBEV-SNT-/ELISA-positive samples that still had sufficient serum volume left (*n*=10), using a commercial indirect immunofluorescence test (immunofluorescence assay (IFA); Biochip Flavivirus-Mosaic-3: TBEV, West Nile virus (WNV), dengue virus (DENV) types 1--4, Japanese encephalitis virus (JEV), and yellow fever virus (YFV); Euroimmun^®^, Germany) adapted to detect porcine antibodies. Louping ill virus (LIV) was investigated by microtitre plate haemagglutination inhibition (HIT) ([@CIT0011]) at Moredun Scientific Research Institute (Scotland, UK). In-house WNV--SNT and Usutu virus (USUV)-SNT tests were performed by Instituto Nacional de Investigación y Tecnologia Agraria y Alimentaria (INIA, Spain) ([@CIT0012], [@CIT0013]). Classical swine fever virus (CSFV)-E2 antibodies were investigated with HerdChek CSFV-ELISA (IDEXX^®^, The Netherlands).

Results {#S0003}
=======

The sample size (*n*=238) was deemed sufficient for the purpose of detecting fairly low design seroprevalence 1.25% (95% confidence; 5% error; required: *n*=227). Provincial sample sizes for Limburg+Antwerp (LIM: sample: *n*=161; subpopulation: *N*\~2,200) and West Flanders (WFL: sample: *n*=77; subpopulation: *N*\~800) were suitable to detect design prevalence of 1.80% (required: *n*=159) and 3.50% (required: *n*=77), respectively.

Seven wild boars were TBEV-seropositive and showed moderate (\>1/15) to high (\>1/125) SNT-titres; three individuals had borderline results (1/10--1/15). Of these 10 reactors, 7 originated in LIM and 3 in WFL ([Fig. 1](#F0001){ref-type="fig"}). The overall Flemish SNT-seroprevalence was estimated around 2.9% (95% CI: 0.79--5.09%; *n* ~SNT+~=7) or 4.20% (95% CI: 1.65--6.75%; *n* ~SNT+~=10), using the 1/15 or 1/10 ([Fig. 1](#F0001){ref-type="fig"}) SNT cut-off, respectively.

The results of the TBEV-ELISA/SNT tests and of the cross-reactivity tests for 10 TBEV-reactor samples, that is, SNT-positive \>1/15, doubtful \>1/10 (*n*=7), or TBEV-ELISA-positive (*n*=3) are summarised in [Table 1](#T0001){ref-type="table"}. Six of these samples selected for cross-reaction testing showed borderline (1/20) or positive (1/40--1/80) reactions in the LIV-HIT. Sample no. 8 tested positive in WNV/USUV-SNT and LIV-HIT. All samples were considered negative in CSFV-ELISA. Highly TBEV-SNT/ELISA-positive samples (no. 2, 3, and 4 in [Table 1](#T0001){ref-type="table"}) reacted TBEV-IFA positive and negative for the other flaviviruses (WNV/JEV/YFV/DENV1-4), while low SNT-positives (sample no. 1, 9, and 10 in [Table 1](#T0001){ref-type="table"}) and SNT-negatives but ELISA-positives (sample no. 5,6, and 7 in [Table 1](#T0001){ref-type="table"}) did not.

###### 

Confirmation panel of 10 TBEV-reactors in SNT and/or ELISA.

       TBEV        TBEV        TBEV          LIV        CSFV   USUV        WNV         WNV      DENV     YFV      JEV
  ---- ----------- ----------- ------------- ---------- ------ ----------- ----------- -------- -------- -------- --------
  1    **POS**     **POS**     NEG           NEG        NEG    NEG         NEG         NEG      NEG      NEG      NEG
       **230**     **1/33**    \<1/10        \<1/20            \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  2    **POS**     **POS**     **POS**       border     NEG    NEG         NEG         NEG      NEG      NEG      NEG
       **\>540**   **1/164**   **1/1,000**   1/20              \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  3    **POS**     **POS**     **POS**       **POS**    NEG    /           /           NEG      NEG      NEG      NEG
       **490**     **1/243**   **1/3,200**   **1/40**                                  \<1/10   \<1/10   \<1/10   \<1/10
  4    **POS**     **POS**     **POS**       **POS**    /      NEG         NEG         NEG      NEG      NEG      NEG
       **520**     **1/127**   **1/3,200**   **1/40**          \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  5    **POS**     NEG         NEG           NEG        NEG    NEG         NEG         NEG      NEG      NEG      NEG
       **\>540**   \<1/10      \<1/10        \<1/20            \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  6    **POS**     NEG         /             border     /      /           /           /        /        /        /
       **430**     \<1/10      /             1/20              /           /           /        /        /        /
  7    **POS**     NEG         NEG           NEG        /      NEG         NEG         NEG      NEG      NEG      NEG
       **265**     \<1/10      \<1/10        \<1/20            \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  8    NEG         **POS**     NEG           **POS**    NEG    **POS**     **POS**     NEG      NEG      NEG      NEG
       15          **1/140**   \<1/10        **1/80**          **1/320**   **1/390**   \<1/10   \<1/10   \<1/10   \<1/10
  9    NEG         **POS**     NEG           border     NEG    NEG         NEG         NEG      NEG      NEG      NEG
       35          **1/17**    \<1/10        1/20              \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10
  10   NEG         **POS**     NEG           NEG        /      NEG         NEG         NEG      NEG      NEG      NEG
       15          **1/25**    \<1/10        \<1/20            \<1/20      \<1/20      \<1/10   \<1/10   \<1/10   \<1/10

TBEV-reactors in TBEV-SNT (*n*=7/10) and reactors in TBEV-ELISA (*n*=3); *n*=7 samples reacted. TBEV: tick-borne encephalitis virus; LIV: louping ill virus; CSFV: classical swine fever virus; USUV: Usutu virus; WNV: West Nile virus; DENV: dengue virus; YFV: yellow fever virus; JEV: Japanese encephalitis virus; IgG: immunoglobulin of subtype G; ELISA: enzyme-linked immunosorbent assay; SNT: seroneutralisation test; IFA: immunofluorescence assay; HIT: haemagglutination inhibition test; PRNT: plaque reduction neutralisation test; Bold=positive result, not bold=negative or borderline result, NEG: negative result; /: no result due to bad quality or lack of volume sample.

Discussion {#S0004}
==========

In a cross-sectional serological screening of a Flemish wild boar population, the TBEV-seroprevalence ranged between 2.90 and 4.20%. We could not substantiate freedom of TBEV (probability of not being infected=0.000), not even in the conservative case using only the SNT-positives (*n*=7 with titre\>1/15). However, the true prevalence can be expected to be below 2.5%. The seropositive and borderline reactors were clustered in a few municipalities in the two subpopulations ([Fig. 1](#F0001){ref-type="fig"}).

Three reactors presented with very high anti-TBEV SNT-titres (\>1/125), supporting classification as true positives. The specificity of the SNT-results was also assessed using a panel of tests. The IFA results confirmed the high specificity of the TBEV-SNT: highly SNT-positive sera also tested TBEV-positive in IFA, whereas SNT-negative/low positive sera did not (samples 8, 9, and 10 in [Table 1](#T0001){ref-type="table"}). This may be due to a superior accuracy (specificity/sensitivity) of the SNT ([@CIT0014], [@CIT0015]). The TBEV-ELISA, on the contrary, did not seem very accurate or robust (see false positives and negatives in [Table 1](#T0001){ref-type="table"}), but the IFA confirmed several of the positive SNT-results. LIV-HIT revealed several positive reactions; however, the titres were markedly lower than the associated TBEV-titres, and most samples were negative in all other tests. Hence, following worldwide accepted specificity criteria, these reactions were mostly TBEV-specific. For sample 8, flaviviral specificity could not be definitively assessed, although this did not seem to be an aspecific or toxic reaction. Although the titres were highest for USUV-/WNV-specificity, TBEV or LIV seem a priori equally likely to emerge in Belgium, and one SNT could not be considered more sensitive than another.

Conclusion {#S0005}
==========

This study has demonstrated the presence of TBEV-specific antibodies in wild boar and potential TBEV-foci at the community level in Flanders. Within its range, a wild boar population can thus effectively be used for local TBEV-sentinel surveillance in low-prevalence areas. Additional active veterinary surveillance and direct virus testing (especially in rodents) are now recommended to attempt TBE-virus detection and to further determine the characteristics of potential endemic foci, while continued passive medical and veterinary surveillance is indicated to monitor the potential risk for Belgian public health.
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